Skip to main content
. 2022 Feb 1;77(7):2211–2221. doi: 10.1111/all.15222

FIGURE 1.

FIGURE 1

Improvement in percentage change from baseline in SNOT‐22 total score (ITT and subgroups). (A) Pooled SINUS‐24 and SINUS‐52 Week 24. (B) SINUS‐52 Week 52. *p < .0001 least squares mean difference dupilumab vs placebo. ITT, intention to treat; NP, nasal polyp; NSAID‐ERD, non‐steroidal anti‐inflammatory drug‐exacerbated respiratory disease; SNOT‐22, 22‐item sino‐nasal outcome test